In vivo administration of l-dopa or dopamine decreases the number of splenic IFNγ-producing cells
Authors:
- Alison TuckerATAlison Tucker
- Rafael Fernandez-BotranRFRafael Fernandez-Botran
- 1 April 2003
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 137 (1-2) , 87-93
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Norepinephrine and β2-Adrenergic Receptor Stimulation Regulate CD4+ T and B Lymphocyte Function in Vitro and in VivoPharmacological Reviews, 2001
- Prolactin in autoimmunity and antitumor defenceJournal of Neuroimmunology, 2000
- Effects of amantadine treatment on in vitro production of interleukin-2 in de-novo patients with idiopathic Parkinson's diseaseJournal of Neuroimmunology, 1999
- Effect of dopamine on immune cell proliferation in miceLife Sciences, 1997
- Dopamine, as well as norepinephrine, is a link between noradrenergic nerve terminals and splenocytesBrain Research, 1997
- EFFECTS OF PROLACTIN AND METOCLOPRAMIDE ON MACROPHAGE CYTOKINE GENE EXPRESSION IN LATE SEPSISCytokine, 1997
- THE PRODUCTION OF SOLUBLE INTERLEUKIN 4 RECEPTORS IS PREFERENTIALLY REGULATED BY THE MURINE Th2CELL SUBSETCytokine, 1997
- Measurements of catecholamine‐mediated apoptosis of immunocompetent cells by capillary electrophoresisElectrophoresis, 1997
- Defective production of interleukin-2 in patients with idiopathic Parkinson's diseaseJournal of the Neurological Sciences, 1995
- Effect of continuous exposure to selective D1 and D2 dopaminergic agonists on rotational behavior in supersensitive mice.The Journal of Pharmacology and Experimental Therapeutics, 1989